Skip to main content
Displaying 13 - 24 of 37
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Novo Nordisk: Navigating MASH patient care (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
The evolving goals of PBC treatment
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Questions and answers
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Demonstrating clinical outcomes through real- world data
Webcasts
View
Immune-Mediated and Cholestatic Diseases
AdvanzPharma: Shifting Paradigms in PBC Management (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Personalised management of MASH (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Updates on the essence of MASH (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Addressing NASH as a chronic metabolic disease: the need for a simplified patient referral pathway
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Page
4
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy